InsiderTrades

Form 4 for EDSA Edesa Biotech, Inc.

Accepted 2022-11-04 00:00:00 ET · period of report 2022-11-02 · accession 0001654954-22-014745 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2022-11-04 2022-11-02 EDSA Nijhawan Pardeep CEO, Dir, 10% A - Grant $1.13 +456.5K 228.3K New +$515.9K
DMI 2022-11-04 2022-11-02 EDSA Nijhawan Pardeep CEO, Dir, 10% A - Grant — +456.5K 114.1K New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2022-11-02 A A 228,262 $1.13 2,356,914 I Held by Pardeep Nijhawan Medicine Professional Corporation — — (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. (F2) Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.
2 Common Common Shares 2022-11-02 A A 228,262 $1.13 228,262 I By Trust — — (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
3 Derivative Common Share Warrants (Right to Buy) 2022-11-02 A A 114,131 — 114,131 I Held by Pardeep Nijhawan Medicine Professional Corporation $1.50 · — to — 114,131 Common Shares (F3) Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. (F2) Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.
4 Derivative Common Share Warrants (Right to Buy) 2022-11-02 A A 114,131 — 114,131 I By Trust $1.50 · — to — 114,131 Common Share (F3) Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date. (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
5 Derivative Common Share Warrants (Right to Buy) 2022-11-02 A A 114,131 — 114,131 I Held by Pardeep Nijhawan Medicine Professional Corporation $1.00 · — to — 114,131 Common Shares (F4) Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share. (F2) Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan.
6 Derivative Common Share Warrants (Right to Buy) 2022-11-02 A A 114,131 — 114,131 I By Trust $1.00 · — to — 114,131 Common Share (F4) Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date. (F1) The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.